Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

I’d buy this FTSE 100 stock, which looks set to thrive in a world with coronavirus

Published 13/05/2020, 11:58
I’d buy this FTSE 100 stock, which looks set to thrive in a world with coronavirus
UK100
-
SGE
-

I last wrote about the FTSE 100’s integrated accounting, payroll, and payments solutions provider Sage (LSE: SGE) on 22 January when the share price was 771p.

The article was bullish and discussed how the company has been changing its business model to focus on building up recurring revenue by moving customers to cloud-based subscription services.

A FTSE 100 stock with a great trading record Sage has a great track record of consistently growing revenue, earnings, cash flow and shareholder dividends. And the way the firm is adapting for the modern ways of doing business encourages me to believe there are many more good years ahead for shareholders.

Shortly after that previous article, the coronavirus crash happened. And by 23 March, the stock was as low as about 530p. In hindsight, that would have been a great entry point for new holders and would have neatly side-stepped the one issue that perhaps keeps investors away from Sage – namely, that the valuation has often looked full.

Since March, the share price has been storming back up and stands at 679p, as I write. But I’d still buy this stock and hold it for the long term. This a high-quality operation with ‘sticky’ revenues and, as such, I see it as an attractive growth-oriented and defensive investment. The recovery from the coronavirus crash demonstrates the firm’s resilience.

Perhaps the most interesting figure in today’s half-year results report is the 2.5% increase in the interim dividend. I reckon that decision by the directors speaks volumes about how they see current trading and the immediate prospects of the business. To pay and increase the dividend when many other companies have axed theirs completely in this crisis strikes me as a sign of the strength of the enterprise.

Growing recurring revenue The company saw an increase in “high quality” recurring revenue of just over 10% in the period. The measure reveals how successful the firm has been attracting new customers and migrating existing customers to subscription and Sage Business Cloud. Overall, organic revenue went up by just under 6%.

Within the figures, we can see the dynamics of Sage’s changing business model in play. There was an almost 26% increase in subscription-based revenue, offset by an almost 20% decline in other revenues. That was due to the managed decline in licence sales and “de-prioritisation” of professional services. Some 88% of the company’s revenue is now recurring, which makes the stock defensive and cash-generating. Ideal for sustaining the progressive shareholder dividend policy.

Covid-19 began to affect non-subscription revenue from the end of March. And now the company is beginning to see the broader effects of the sharp economic downturn caused by the pandemic. Some of the firm’s customers are deferring purchase decisions. Indeed, during April, new customer acquisition was roughly half the level the directors had previously expected.

However, Sage doesn’t intend to make any of its staff redundant and hasn’t furloughed anyone, or taken advantage of other government support schemes. Despite the near-term uncertainty, the directors are “confident” about the company’s long-term strategy. And I reckon Sage looks set to thrive in a world with coronavirus.

The post I’d buy this FTSE 100 stock, which looks set to thrive in a world with coronavirus appeared first on The Motley Fool UK.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended Sage Group (LON:SGE). Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Motley Fool UK 2020

First published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.